Osteoclastic Giant Cell-Rich Tumor of Bone

Osteoclastic Giant Cell-Rich Tumor of Bone — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03620149	Reduced Dose-density of Denosumab for Unresectable GCTB(REDUCE)	terminated	Phase 2	2	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	4	Jan 6, 2021	clinicaltrials
NCT00889590	Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)(HR-GCT)	terminated	Phase 2	15	Leiden University Medical CenterOTHER	2